Tubular tRF‑1:30‑Gln‑CTG‑4 attenuates tubulointerstitial fibrosis by mitigating FBXO7-mediated mitophagy defect in diabetic kidney disease

Cell Death and Disease · Published 2026-07-18 · DOI 10.1038/s41419-026-09112-2

Free full text

Authors (13)

Jia-ling Ji, Yun-yang Qiao, Jia-yue Sun, Ying Huo, Hui-min Shi, Gao-ting Qu, Shan-wen Li, Chan Huang, Yu Feng, Pei Zhang, Ling Ding, Zuo-lin Li, Ai-qing Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ji, J., Qiao, Y., Sun, J., et al. (2026). Tubular tRF‑1:30‑Gln‑CTG‑4 attenuates tubulointerstitial fibrosis by mitigating FBXO7-mediated mitophagy defect in diabetic kidney disease. Cell Death and Disease. https://doi.org/10.1038/s41419-026-09112-2

Related articles

• Single-cell profiling uncovers a rare mesenchymal-like urothelial state associated with sarcomatoid bladder cancer · Cell Death and Disease · 2026 · Same journal
• BAP1 deficiency-induced SKA3 promotes clear cell renal cell carcinoma malignant progression by regulating chromosomal instability · Cell Death and Disease · 2026 · Same journal
• AARS1-catalyzed H4K12 lactylation promotes HCC resistance to targeted therapy by activating RAPGEF3-RAP1 signaling · Cell Death and Disease · 2026 · Same journal
• MARCKS as a mediator and target for pathological tunneling nanotubes between patient-derived glioblastoma cells and astrocytes · Cell Death and Disease · 2026 · Same journal
• The PLAU-ITGB1-TGF-β axis orchestrates spatiotemporal reprogramming of fibroblasts at the invasive front to drive dual immunosuppressive niche and immunotherapy resistance in oral squamous cell carcinoma · Cell Death and Disease · 2026 · Same journal
• Mycobacterium tuberculosis infects human peripheral hematopoietic multipotent progenitors and promotes their myeloid differentiation in vitro · Cell Death and Disease · 2026 · Same journal
• Targeted degradation of P-TEFb via MDM2 substrate substitution collapses oncogenic transcriptional programs in MDM2-amplified cancers · Cell Death and Disease · 2026 · Same journal
• SLC25A20 promotes tumor growth by reprogramming energy metabolism in lung adenocarcinoma · Cell Death and Disease · 2026 · Same journal
• Caspase-3 regulates RNA splicing and mitochondrial dynamics in microglia during Parkinson’s disease · Cell Death and Disease · 2026 · Same journal
• MAP2K6 reprograms NAD+ metabolism via the HMGA1–NAMPT axis to sensitize ovarian cancer cells to PARP inhibition · Cell Death and Disease · 2026 · Same journal